docHodgkin Lymphoma Market 10 Year Epidemiology Forecasts in 7 Major Markets
download 
Report Transcription
Hodgkin Lymphoma Market 10 Year Epidemiology Forecasts in 7 Major Markets The Hodgkin’s lymphoma treatment market is set to increase more than fourfold from $316 million in 2014 to $1.4 billion by 2024, representing a Compound Annual Growth Rate (CAGR) of 16%. Hodgkin’s lymphoma (HL), or Hodgkin’s disease, is a malignancy which involves the lymph nodes and the lymphatic system. HL is a relatively rare type of cancer, accounting for 12% of all lymphomas and 0.6% of all new cancer cases, but overall prognosis is very good. However, treatment options for those patients who have failed first-line treatment are very few, and a significant unmet medical need remains in those patients Hodgkin Lymphoma Market research report Provides analysis of the current and future market competition in the global HL market. Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications. Browse Detailed Toc, Tables, Figures, Charts and Companies Mentioned in Hodgkin’s Lymphoma (Hl) Opportunity Analysis and Forecasts Report at - http://www.absolutereports.com/opportunityanalyzerhodgkin-s-lymphoma-hl-opportunity-analysis-and-forecasts-to-2024-10120404 According to this latest report,” Hodgkin’s Lymphoma (Hl) - Opportunity Analysis and Forecasts” this impressive growth, which will occur across the seven Major Markets (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, will be attributable to label extensions for Seattle Genetics’ Adcetris into earlier lines of treatment, and the launch of new therapies for relapse or refractory (R/R) Hodgkin’s lymphoma. Ask for Discount on Hodgkin’s Lymphoma (Hl) - Opportunity Analysis and Forecasts Report at – http://www.absolutereports.com/enquiry/request-discount/10120404 Scope of the Report: - Overview of HL, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, disease management, and current treatment options. - Top-line HL therapeutics market revenue from 2014-2024. Average cost of therapy (ACOT) and major pipeline product sales in this forecast period are included. - Key topics covered include strategic competitor assessment, market characterization, unmet needs, R&D strategies, and clinical trial design for the HL market. - Pipeline analysis: comprehensive data split across different phases, emerging novel trends under +1 408 520 9750 www.absolutereports.com development, synopses of innovative early-stage projects, and detailed analysis of late-stage pipeline products. An interactive clinical and commercial analyzer tool is available. Request sample PDF of this report at - http://www.absolutereports.com/enquiry/requestsample/10120404 Reasons to buy The report will enable you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global HL market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global HL market in the future. About Absolute Report: Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters. Contact– Mr. Ameya Pingaley Absolute Reports +1-408 520 9750 Email – sales@absolutereports.com Website: www.absolutereports.com +1 408 520 9750 www.absolutereports.com
Similar documents
Medtronic plc, Bioventus LLC and Depuy Companies Dominate the UK Orthobiologics Market Report
The orthobiologics market in the UK is expected to be driven by patient demographics, the development of novel product designs, increasing patient awareness, increasing participation in sports related activities, and a rising incidence of road accidents. The data in the report is derived from dynamic market forecast models.
Ventricular Fibrillation: Global Industry Analysis, Trends, Market Demands, Segment and Forecast
Ventricular Fibrillation- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries and regions. While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the drug master filings across the US, Europe and Asia specifically China and India.
First Electric Cooperative Corporation, Update 2015
The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services.
France Orthopedic Prosthetics Procedure report to 2021, Market Shares, Research Report, Industry Analysis, Forecast Opportunity
prosthesis is a functional replacement for an amputated or congenitally malformed or missing limb. Prosthetists are responsible for the prescription, design and management of a prosthetic device. In most cases, the prosthetist begins by taking a plaster cast of the patient's affected limb. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Lower Extremity Prosthetics and Upper Extremity Prosthetics.
Latest Research Report on Medical Equipment Monthly Deals Analysis: JANUARY 2016 - M&A and Investment Trends
Medical Equipment Monthly Deals Analysis: JANUARY 2016 report provides detailed information on M&As, equity/debt offerings, private equity, venture financing and partnership transactions registered in the medical equipment industry in January 2016.
Latest Report: Glioblastoma Treatment Market Will Expand Fivefold to $3.3 Billion at a CAGR of 17.4% by 2024
The glioblastoma treatment market will increase fivefold from $659 million in 2014 to $3.3 billion by 2024, representing a rapid Compound Annual Growth Rate (CAGR) of 17.4% according to a leading research and consulting firm. Of the 7MM, Japan will see the most impressive relative growth, with sales expanding from $47 million in 2014 to $268 million in 2024, representing a CAGR of 19.7%.
Human Immunodeficiency Virus (Hiv) Therapeutics Market Worth Will Be $15 billion in Sales by 2023
The global HIV therapeutics market was worth approximately $14 billion in 2013, and it is expected to rise a total of $15 billion in sales by 2023, at a Compound Annual Growth Rate (CAGR) of 0.9%. These sales are expected to come predominantly from the US market, as financial austerity measures remain a primary barrier to the growth of the HIV market in the other countries covered in this report.
Latest Research: US Will Remain Hernia Repair Market Leader by 2021
The overall US hernia repair market is expected to rise to approximately $1.2 billion by 2021, at a moderate Compound Annual Growth Rate (CAGR) of 4%. It was valued at approximately $875 million in 2014. The US has a higher adoption of expensive meshes in general, and procedure volume will go up by 1% annually. For example, the majority of umbilical hernia repairs are performed with composite meshes, which contribute to a higher market valuation.
Clinical Cancer Research Highlights of This Issue 5145 SPECIAL FEATURES CCR Translations
UK Hip Reconstruction Market Forecast till 2021: Present and Future Trends and Growth Opportunities
The report firstly introduced the HIP Reconstruction basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level.
Follicular Lymphoma Market Treatment, Analysis, Outlook and Pipeline Review, H1 2016
Global Markets Direct's, 'Follicular Lymphoma - Pipeline Review, H1 2016', provides an overview of the Follicular Lymphoma pipeline landscape
Visit Us @ http://www.radiantinsights.com/research/follicular-lymphoma-pipeline-review-h1-2016